Table 2.
Bio-marker expression between primary lesions and metastatic lymph nodes in patients with different subtypes of lung cancer.
Small-cell (n=5) | Large-cell (n=4) | Squamous-cell (n=24) | Adenocarcinoma (n=15) | P value | |
---|---|---|---|---|---|
MDR-1 | 1 (25%) | 1 (25%) | 6 (25%) | 3 (20%) | 1.000 |
LRP | 1 (20%) | 3 (75%) | 9 (37%) | 5 (33%) | 0.449 |
RRM-1 | 3 (60%) | 1 (25%) | 7 (29%) | 9 (60%) | 0.190 |
EGFR | 2 (40%) | 1 (25%) | 10 (42%) | 7 (47%) | 0.965 |
ERCC-1 | 0 (0.0%) | 2 (50%) | 8 (33%) | 6 (40%) | 0.345 |
BRCA-1 | 2 (40%) | 2 (50%) | 3 (13%) | 7 (47%) | 0.051 |